|||||
3-methylcrotonylglycinurie (aandoening)
3-methylcrotonylglycinurie
3-methylcrotonyl-CoA-carboxylasedeficiëntie
3-MCC-deficiëntie
3-methylcrotonyl-CoA-carboxylasedeficiëntie
Dit is een erfelijke stofwisselingsziekte waarbij het aminozuur leucine niet goed wordt afgebroken. Dit kan leiden tot hersenbeschadiging, epilepsie en een ontwikkelingsachterstand. De ziekte is goed behandelbaar.
Methylcrotonyl-CoA carboxylase deficiency
3-Methylcrotonyl-CoA carboxylase deficiency
Methylcrotonyl-coenzyme A carboxylase deficiency
beta-Methylcrotonylglycinuria, type 1
MCC deficiency
BMCC deficiency
An inherited disorder of leucine metabolism with characteristics of a highly variable clinical picture ranging from metabolic crisis in infancy to asymptomatic adults. Patients have a variable clinical phenotype with the vast majority of patients being asymptomatic and a small subgroup displaying symptoms of an organic aciduria, usually in association with environmental triggering factors. This disease is due to mutations in the MCCC1 (3q27.1) or MCCC2 (5q12-q13) genes. Mutations in these genes lead to reduced or absent 3-MCC activity, thereby allowing the toxic byproducts of leucine processing to build up and cause clinical symptoms. Inherited autosomal recessively.
Id13144005
StatusPrimitive
Occurrencecongenitaal
DHD Diagnosis thesaurus reference set
RIVM authorized national diagnosis thesaurus to ICD10 complex mapping reference set
TargetE71.2
TermStofwisselingsstoornis van aminozuren met vertakte keten, niet gespecificeerd
SNOMED CT to Orphanet simple map6
SNOMED CT to ICD-10 extended map
TargetE71.1
RuleTRUE
AdviceALWAYS E71.1
CorrelationSNOMED CT source code to target map code correlation not specified